A Novel Markov Model Projecting Costs and Outcomes of Providing Antiretroviral Therapy to Public Patients in Private Practices versus Public Clinics in South Africa

Open Access

Peer-reviewed

Research Article

Rory Leisegang,

Affiliation Division of Clinical Pharmacology, University of Cape Town, Cape Town, South Africa
⨯
Gary Maartens ,

* E-mail: gary.maartens@uct.ac.za

Affiliation Division of Clinical Pharmacology, University of Cape Town, Cape Town, South Africa
⨯
Michael Hislop,

Affiliation Aid for AIDS, Medscheme Pty Limited, Cape Town, South Africa
⨯
John Sargent,

Affiliation BroadReach Healthcare, Cape Town, South Africa
⨯
Ernest Darkoh,

Affiliation BroadReach Healthcare, Cape Town, South Africa
⨯
Susan Cleary

Affiliation Health Economics Unit, University of Cape Town, Cape Town, South Africa
⨯

Reader Comments (0)

Antiretroviral therapy
Is the Subject Area "Antiretroviral therapy" applicable to this article?

Thanks for your feedback.
Markov models
Is the Subject Area "Markov models" applicable to this article?

Thanks for your feedback.
South Africa
Is the Subject Area "South Africa" applicable to this article?

Thanks for your feedback.
Monte Carlo method
Is the Subject Area "Monte Carlo method" applicable to this article?

Thanks for your feedback.
Toxicity
Is the Subject Area "Toxicity" applicable to this article?

Thanks for your feedback.
Viral load
Is the Subject Area "Viral load" applicable to this article?

Thanks for your feedback.
Nurses
Is the Subject Area "Nurses" applicable to this article?

Thanks for your feedback.
HIV epidemiology
Is the Subject Area "HIV epidemiology" applicable to this article?

Thanks for your feedback.